-
1Academic JournalPotent Cyclic Peptide Inhibitors of FXIIa Discovered by mRNA Display with Genetic Code Reprogramming
المؤلفون: Daniel J. Ford (10888333), Nisharnthi M. Duggan (10888336), Sarah E. Fry (10888339), Jorge Ripoll-Rozada (5025497), Stijn M. Agten (1428757), Wenyu Liu (441933), Leo Corcilius (1883605), Tilman M. Hackeng (248145), Rene van Oerle (5655286), Henri M. H. Spronk (10698591), Anneliese S. Ashhurst (3555530), Vishnu Mini Sasi (10888342), Joe A. Kaczmarski (4288417), Colin J. Jackson (153786), Pedro José Barbosa Pereira (5025500), Toby Passioura (5715143), Hiroaki Suga (295809), Richard J. Payne (401410)
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Cell Biology, Pharmacology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, FXIIa, Potent Cyclic Peptide Inhibitors, generation, series, Genetic Code Reprogramming, mRNA display technology, contact system, binding, cyclic peptide inhibitors, Randomised Nonstandard Peptide Inte.
-
2Potent Cyclic Peptide Inhibitors of FXIIa Discovered by mRNA Display with Genetic Code Reprogramming
المؤلفون: Daniel J. Ford (10888333), Nisharnthi M. Duggan (10888336), Sarah E. Fry (10888339), Jorge Ripoll-Rozada (5025497), Stijn M. Agten (1428757), Wenyu Liu (441933), Leo Corcilius (1883605), Tilman M. Hackeng (248145), Rene van Oerle (5655286), Henri M. H. Spronk (10698591), Anneliese S. Ashhurst (3555530), Vishnu Mini Sasi (10888342), Joe A. Kaczmarski (4288417), Colin J. Jackson (153786), Pedro José Barbosa Pereira (5025500), Toby Passioura (5715143), Hiroaki Suga (295809), Richard J. Payne (401410)
مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Cell Biology, Pharmacology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, FXIIa, Potent Cyclic Peptide Inhibitors, generation, series, Genetic Code Reprogramming, mRNA display technology, contact system, binding, cyclic peptide inhibitors, Randomised Nonstandard Peptide Inte.